Study of Chemotherapy in Combination With All-trans Retinoic Acid (ATRA) With or Without Gemtuzumab Ozogamicin in Patients With Acute Myeloid Leukemia (AML) and Mutant Nucleophosmin-1 (NPM1) Gene Mutation
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Study of Reduced Toxicity Myeloablative Conditioning Regimen for Cord Blood Transplantation in Pediatric AML
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study of the Efficacy and Safety of Lenalidomide Combined to Escalating Doses of Chemotherapy in Intermediate-2-or High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) With Del 5q
- Status
- UNKNOWN
- Phase
- PHASE2
Effect of Priming During Induction and Consolidations in Younger Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE3
Trial of PXD101 (Belinostat) in Combination With Idarubicin to Treat AML Not Suitable for Standard Intensive Therapy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Decitabine Alone or in Combination With Valproic Acid and All-trans Retinoic Acid in Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of Low-Dose Intravenous Decitabine in Patients Aged > 60 Years With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Decitabine in Combination With Escalating Doses of Rapamycin in Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk
- Status
- COMPLETED
- Phase
- PHASE3
Study of 72-Hour Infusion of ON 01910.Na in Patients With MDS or AML
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias
- Status
- TERMINATED
- Phase
- PHASE1
Lenalidomide In Patients With Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Phase III Trial Treosulfan-based Conditioning Versus Reduced-intensity Conditioning (RIC)
- Status
- COMPLETED
- Phase
- PHASE3
Trial of CPX-351 in Adult Patients With First Relapse Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE2
RAD001 in Combination With PKC412 in Patients With Relapsed, Refractory or Poor Prognosis AML or MDS
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Collection and Banking of Leukemia Cells MDS/AML
- Status
- COMPLETED
- Phase
- NA
Vaccination With GM-K562 Cells in Patients With Advanced Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) After Allogeneic Hematopoetic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1